AI concerns pressure chipmakers premarket; UPS, Carrier rise By Investing.com
U.S. stock futures were mixed as renewed concerns about AI spending weighed on semiconductor shares ahead of major tech earnings and the Fed. Chipmakers fell broadly after an Asian selloff and worries about AI infrastructure financing and China competition, plus a CXMT IPO. UPS and Carrier rose on Q2 results and raised guidance; Altimmune, ProMIS, BuzzFeed, and Cadence also gained.
How this was made
The 30-second read
Why it matters
Traders can use the premarket catalysts for UPS, Carrier, Cadence, and the biotech trial updates to position for continued momentum, while treating the broader semiconductor declines as sentiment-driven until a company-specific catalyst appears.
Market read
This is a premarket catalyst mix: several single-name earnings and clinical-trial updates support upside momentum, while semiconductors are broadly sold on AI spending and China competition fears ahead of the Fed and mega-cap tech earnings.
What to watch
The article’s semi weakness is largely narrative-driven (AI capex sustainability, financing costs, China competition) and may reverse if mega-cap tech earnings or the Fed decision reduce rate/financing fears.
Background
The piece frames mixed U.S. futures and a premarket rotation: semiconductors are pressured by AI spending sustainability concerns, while several non-semi names move on earnings beats or clinical trial readouts.
Ticker impact
UPS gained 2.1% premarket after reporting Q2 results that beat expectations and raising full-year outlook.
Bullish bias for the session, with follow-through dependent on broader semis/AI risk sentiment.
The article provides explicit EPS, revenue, and guidance-upgrade details tied to the premarket move.
Carrier rose 3.0% premarket after stronger-than-expected Q2 earnings and increased full-year guidance.
Moderately bullish near-term, especially if investors rotate into non-semi cyclicals.
The text includes beat figures and a specific strategic asset sale (NORESCO) that can affect sentiment.
ProMIS Neurosciences climbed 13% premarket on positive interim safety and biomarker data from Phase 1b Alzheimer’s trial for PMN310.
Bullish bias with elevated volatility until more efficacy data emerge.
The article provides specific safety observations (no ARIA-E) and mild, asymptomatic microhaemorrhages.
BuzzFeed jumped 14.2% premarket after unveiling a restructuring plan to eliminate about 35% of its workforce.
Short-term upside likely, but follow-through depends on financing and realized savings.
The article discloses the scale of workforce reduction and the stated goal of improving long-term financial performance.
Cadence Design Systems gained 2.7% premarket after Q2 earnings and revenue beat and raised full-year guidance.
Mild-to-moderate bullish bias, potentially benefiting from AI capex narratives despite broader semi weakness.
The text includes beat and a specific driver: revenue rose 24% YoY with accelerating AI-driven chip design tools demand.
Amkor Technology fell 5.3% premarket despite record Q2 revenue and earnings, due to weaker-than-expected Q3 revenue guidance.
Bearish near-term, with downside risk if the market extrapolates further demand softness.
The article explicitly attributes the decline to third-quarter revenue guidance below Wall Street forecasts.
The article asks 'Is now the time to buy INTC?' but provides no new INTC-specific fundamental data beyond the broader AI/semis pressure.
No reliable directional signal from this text alone.
The only INTC content is a marketing-style evaluation prompt, without new guidance, results, or filings.
Micron fell around 4% premarket as investors questioned AI spending sustainability and rising Chinese competition.
Near-term bearish bias tied to broader semi sentiment.
The article attributes the move to general sector concerns, with no Micron-specific new fact.
Market effects
AI spending sustainability worries and China competition concerns are pressuring the semiconductor complex, likely raising volatility around AI-exposed supply chain names.
Asian semiconductor selloff overnight is cited as a driver of premarket weakness in U.S. chipmakers.
Memory competition fears are reinforced by a major Shanghai IPO, potentially affecting global memory pricing expectations.
Counterpoint
Some premarket strength (UPS, Carrier, Cadence) suggests investors may be rotating into earnings quality and AI-enablement beneficiaries rather than exiting the theme entirely.
Key entities
- companyUnited Parcel Service
Reported Q2 results that beat expectations and raised full-year outlook, lifting premarket shares.
- companyCarrier Global
Reported stronger-than-expected Q2 earnings and increased full-year guidance, also announcing a NORESCO sale.
- companyAltimmune
Reported positive Phase 2 RECLAIM topline results meeting the primary endpoint for pemvidutide.
- companyProMIS Neurosciences
Reported positive interim safety and biomarker data from Phase 1b Alzheimer’s trial for PMN310.
- companyBuzzFeed
Announced a restructuring plan to eliminate about 35% of workforce across its brands.
